The Society for Heart Valve Disease

 

 

 

2011 Postgraduate Course Programme

POSTGRADUATE COURSE PROGRAMME:
“Clinical Research Update and Transcatheter Valve Therapy”
Course Directors: David Adams, Jeffrey Borer, Michael Borger, Johanna Takkenberg
Saturday, June 25
07:00 - 08:00   Registration
I. Valvular Therapy Potpourri (08:00 – 09:30)
Moderators: Maurice Sarano (Rochester), David Adams (New York) 
08:00 - 08:20   Epidemiology, classification, and clinical relevance of bicuspid aortic valve disease – Efstratios I. Charitos (Luebeck)
08:20 - 08:40   Surgical considerations for the bicuspid aortic valve – John Ikonomidis (Charleston)
08:40 - 09:00   Severe mitral regurgitation: When should patients be referred for surgery? When should they be observed? – Maurice Sarano (Rochester)
09:00 - 09:20   Barlow’s disease and fibroelastic deficiency: Why is it important to differentiate? – David Adams (New York)
09:20 - 09:30   Discussion
09:30 - 10:00   Coffee Break
II. Clinical Research Update (10:00 – 12:30)
Moderators: Michael Borger (Leipzig), Johanna Takkenberg (Rotterdam)
10:00 - 10:20   PARTNER Trial Arms A and B: Good news for everyone? – Thomas Walther (Bad Nauheim)
10:20 - 10:40   EVEREST II Trial: Where do we go from here? – Holger Thiele (Leipzig)
10:40 - 11:00   Randomized trials in valvular heart therapy: Are they feasible? – Jeffrey Borer (New York)
11:00 - 11:20   Statin therapy for aortic valvular disease: Is there still a role? – Johanna Takkenberg (Rotterdam)
11:20 - 11:40   Minimal invasive versus conventional mitral valve surgery: ISMICS position paper – Ehud Raanani (Tel HaShomer)
11:40 - 12:00   Dabigatran for prevention of thromboembolism in atrial fibrillation: Implications for mechanical valve therapy? – Mostafa Mokhles (Rotterdam)
12:00 - 12:20   STICH trial: Results, insights and implications (including for the mitral valve) – Robert Bonow (Chicago)
12:20 - 12:30   Discussion
12:30 - 13:30   Lunch Break
III. Transcatheter Therapy (13:30 – 15:30)
Moderators: Blase Carabello (Houston), Ruediger Lange (Munich)
13:30 - 13:50   Starting a successful transapical program – Ruediger Lange (Munich)
13:50 - 14:10   TAVI therapy: A cardiologist’s perspective - Blase Carabello (Houston)
14:10 - 14:30   Elective and emergent valve-in-valve therapy: Indications and results – Joerg Kempfert (Bad Nauheim)
14:30 - 14:50   Echocardiography during TAVI: Is it necessary? - Joerg Ender (Leipzig)
14:50 - 15:10   Transapical MV repair / replacement: What does the future hold? – Francesco Maisano (Milan)
15:10 - 15:30   Discussion
15:30 - 16:00   Coffee Break
IV. The Future (16:00 – 17:15)
16:00 - 16:20   Mitral valve rings: Which device for which patients? – Robert Klautz (Leiden)
16:20 - 16:40   Functional heart valve tissue engineering – Carlijn Bouten (Eindhoven)
16:40 - 17:10   Special Lecture “What the future cardiac surgeon needs to know and do” - Fred Mohr (Leipzig)
17:10 - 17:15   Closing Remarks - Jeffrey Borer (New York)
17:30   Biennial Meeting Welcome Reception
Blue Salon, Hotel Rey Juan Carlos

  Copyright © 1998-2012 The Society for Heart Valve Disease. Privacy Policy